株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

新たなインスリン製剤と投与技術の世界市場−インスリンポンプを中心に

Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin Pumps

発行 BCC Research 商品コード 281733
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
新たなインスリン製剤と投与技術の世界市場−インスリンポンプを中心に Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin Pumps
出版日: 2013年08月30日 ページ情報: 英文 128 Pages
概要

インスリン製剤と新たな投与技術は、血糖管理の改善、投与法の改善と普及などを促進することにより糖尿病治療の市場で確固とした地位を築く可能性があります。すでに製薬会社や研究機関は、成人や若年の患者が糖尿病を管理できるようにするための新たな手法の研究に着手しており、今後これらの技術の安定的な市場が構築されると期待されています。新技術の開発を促す原動力になっているのは、研究開発への支出、競争の激化、特許の期限切れ、新技術の登場といった要因であり、新たな進歩、新製品の投入、認知度の向上、病気の早期発見などの動きとも相まって市場の拡大に大きな影響を及ぼしています。

当レポートは、インスリンポンプに焦点を絞り込みながら世界の新たなインスリン製剤とデリバリー技術の市場を調査し、その将来像を展望するもので、各種の新たな投薬技術の開発状況、規制や特許の分析、各地域市場の動向などに加え、主要企業各社のプロファイルも盛り込み、概略下記の構成でお届けします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 糖尿病の概要
  • 糖尿病の分類
  • 疫学
  • 1型糖尿病の管理
  • インスリン
  • インスリンの構造
  • インスリンの生合成
  • インスリンのタイプ
  • 治療プロトコル
  • 投与ルート

第4章 法規制の諸側面

  • インスリン製剤の承認
  • インスリン投与器具に対して与えられた承認
  • 市場投入前の通知手続き
  • 安全警報と回収

第5章 新たな動き

  • インスリン投与のための新技術
  • 製品開発
  • 合併と買収
  • ライセンス供与、提携、協定
  • パイプライン上の製品

第6章 世界市場

  • タイプ別市場
  • 地域別市場
  • インスリン注射器とバイアル
  • インスリンペン型注入器
  • インスリンポンプ
  • 用途別市場

第7章 インスリンポンプ市場の分析

  • タイプ別市場
  • 地域別市場
  • 管付きのインスリンポンプ
  • 管のないインスリンポンプ
  • インプラント式インスリンポンプ
  • 市場シェア
  • 用途別市場
  • 業界の構造

第8章 特許についての分析

  • 各年の特許承認状況
  • 各種製品の特許承認状況
  • 各社の特許承認状況
  • 各国の特許承認状況
  • 各種出願人の特許承認状況

第9章 市場の現状

  • 市場のトレンド
  • インスリンポンプ
  • 人工すい臓
  • 閉ループインスリンポンプ
  • インスリンペン型注入器
  • インスリン注射器
  • 最新のインスリン投与法
  • 経口インスリン製剤
  • インスリン鼻スプレー
  • バイオシミラーインスリン
  • インスリン投与器具市場の成長を促す要因
  • インスリン投与器具市場に大きな影響を及ぼしている要因
  • 提携、合併、買収

第10章 主要企業のプロファイル

  • ADOCIA
  • ANIMAS CORPORATION
  • ANTRIABIO
  • BECTON, DICKINSON AND COMPANY
  • BIOCON LIMITED
  • BIODEL INC.
  • DEBIOTECH
  • ELI LILLY
  • ETERNITY HEALTHCARE
  • F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG)
  • GENEREX BIOTECHNOLOGY CORPORATION
  • HALOZYME THERAPEUTICS INC.
  • INSULINE MEDICAL
  • INSULUTION ABM
  • LIFESCAN
  • MANNKIND
  • MARINA BIOTECH INC.
  • MEDTRONIC INC.
  • MICROPORT SCIENTIFIC CORPORATION
  • MIDASOL THERAPEUTICS (MIDATECH LTD.とMONOSOL RXの合弁会社)
  • NOVO NORDISK
  • ORAMED PHARMACEUTICALS INC.
  • PHOSPHAGENICS LIMITED
  • SANOFI
  • SENSILE MEDICAL AG
  • THERMALIN DIABETES INC.
  • XERIS PHARMACEUTICALS
  • YPSOMED HOLDING AG

図表

目次
Product Code: HLC158A

REPORT HIGHLIGHTS

This report provides:

  • An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin pumps.
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
  • Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
  • Patent identifications for insulin as a drug, along with its delivery methods.

STUDY OBJECTIVES

BCC Research's objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices.

This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market's improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.

A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018.

Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.

Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.

Companies' acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.

SCOPE OF THE STUDY

The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.

The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.

The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 14 years of industry experience. She has worked studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid, along others. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has also worked with top companies in India and in the U.S.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in the life sciences. She has a number of research publications to her credit.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND FOR WHOM
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, 2011-2018 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • DIABETES OVERVIEW
  • DIABETES CLASSIFICATION
    • TABLE 1: DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES
  • EPIDEMIOLOGY
    • TABLE 2: ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH RESPECT TO 2000
  • TYPE 1 DIABETES MELLITUS MANAGEMENT
  • INSULIN
    • HISTORY OF INSULIN ISOLATION AND THE DEVELOPMENT OF ITS ANALOGS
      • TABLE 3: HISTORY OF INSULIN ISOLATION AND DEVELOPMENT
    • STRUCTURE OF INSULIN
    • INSULIN BIOSYNTHESIS
    • INSULIN TYPES
      • TABLE 4: CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS
  • TREATMENT PROTOCOL
    • Multiple Daily Injections
      • TABLE 5: ADVANTAGES AND DISADVANTAGES OF SYRINGES
    • Continuous Subcutaneous Insulin Infusion and Insulin Pump Therapy
      • TABLE 6: INSULIN PUMPS CURRENTLY ON THE MARKET
      • TABLE 7: COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR VARIOUS INSULIN DELIVERY SYSTEMS
      • TABLE 8: INSULIN PENS CURRENTLY ON THE MARKET
  • ADMINISTRATION ROUTES
    • TABLE 9: INSULIN ADMINISTRATION ROUTES

CHAPTER 4 - REGULATORY ASPECTS

  • APPROVALS FOR INSULIN DRUGS
    • TABLE 10: INSULIN DRUG APPROVALS, 2009-MARCH 2013
  • APPROVALS GRANTED FOR INSULIN DEVICES
    • TABLE 11: PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN DEVICES, 2009-MARCH 2013
  • PREMARKET NOTIFICATION OR 510(K) CLEARANCE
    • TABLE 12: PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN DEVICES, 2009-MARCH 2013
  • SAFETY ALERTS AND RECALLS
    • TABLE 13: SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013
    • TABLE 14: DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013

CHAPTER 5 - NEW DEVELOPMENTS

  • NEW TECHNOLOGIES FOR INSULIN DELIVERY
    • INSULIN INHALERS
    • INSULIN SPRAY
    • IMPLANTABLE INSULIN PUMPS
    • TRANSDERMAL PATCH
    • PRODUCT DEVELOPMENT
      • TABLE 15: NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
    • MERGERS AND ACQUISITIONS
      • TABLE 16: INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND ACQUISITIONS
    • LICENSING, PARTNERSHIPS, AND AGREEMENTS
      • TABLE 17: LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
    • PIPELINE PRODUCTS
      • TABLE 18: INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS

CHAPTER 6 - GLOBAL MARKETS

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 19: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
      • FIGURE 1: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, 2011-2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 20: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%)
      • FIGURE 2: INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 21: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 3: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 22: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012 (%)
      • FIGURE 4: INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%)
  • INSULIN SYRINGES AND VIALS
    • Market Overview
    • Market Revenue
      • TABLE 23: GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 5: GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • Market Share
      • TABLE 24: INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%)
      • FIGURE 6: INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%)
  • INSULIN PENS
    • Market Overview
    • Market Revenue
      • TABLE 25: GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 7: GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • Market Share
      • TABLE 26: INSULIN PEN MARKET SHARES BY REGION, 2012 (%)
      • FIGURE 8: INSULIN PEN MARKET SHARES BY REGION, 2012 (%)
  • INSULIN PUMPS
    • Market Overview
    • Market Revenue
      • TABLE 27: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 9: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Share
      • TABLE 28: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
      • FIGURE 10: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
  • MARKET BY APPLICATIONS
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 29: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 11: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 30: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012 (%)
      • FIGURE 12: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012 (%)

CHAPTER 7 - INSULIN PUMP MARKET ANALYSIS

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 31: GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
      • FIGURE 13: GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 32: INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%)
      • FIGURE 14: INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 33: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 15: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
  • INSULIN PUMPS WITH TUBING
    • Market Overview
    • Market Revenue
      • TABLE 34: GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 16: GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
  • TUBELESS INSULIN PUMPS
    • Market Overview
    • Market Revenue
      • TABLE 35: GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 17: GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011-2018 ($ MILLIONS)
  • IMPLANTABLE INSULIN PUMPS
    • Market Overview
    • Market Revenue
      • TABLE 36: GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 18: GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 37: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
      • FIGURE 19: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
  • MARKET BY APPLICATIONS
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 38: GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
      • FIGURE 20: GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 39: INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%)
      • FIGURE 21: INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%)
  • INDUSTRY STRUCTURE
    • MARKET LEADERS
      • TABLE 40: LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS
    • MARKET SHARES
      • TABLE 41: INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%)
      • FIGURE 22: INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%)

CHAPTER 8 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 42: U.S. PATENTS, JANUARY 2009-MARCH 2013 (%)
    • FIGURE 23: U.S. PATENTS, JANUARY 2009-MARCH 2013 (%)
  • PATENTS BY TYPE
    • TABLE 43: U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
    • FIGURE 24: U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
  • PATENTS BY COMPANY
    • TABLE 44: U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013
  • PATENTS BY COUNTRY
    • TABLE 45: U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
    • FIGURE 25: U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
  • PATENTS BY ASSIGNEE
    • TABLE 46: U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013
    • FIGURE 26: U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013

CHAPTER 9 - CURRENT SITUATION

  • MARKET TRENDS
    • INSULIN PUMPS
      • Artificial Pancreas
      • Closed-Loop Insulin Pump
    • INSULIN PENS
    • INSULIN SYRINGES
  • MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS
    • ORAL INSULIN
    • NASAL INSULIN SPRAY
    • BIOSIMILAR INSULIN
  • OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET
  • FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET
  • COLLABORATIONS, MERGERS AND AQUISITIONS

CHAPTER 10 - COMPANY PROFILES

  • ADOCIA
  • ANIMAS CORPORATION
  • ANTRIABIO
  • BECTON, DICKINSON AND COMPANY
  • BIOCON LIMITED
  • BIODEL INC.
  • DEBIOTECH
  • ELI LILLY
  • ETERNITY HEALTHCARE
  • F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG)
  • GENEREX BIOTECHNOLOGY CORPORATION
  • HALOZYME THERAPEUTICS INC.
  • INSULINE MEDICAL
  • INSULUTION ABM
  • LIFESCAN
  • MANNKIND
  • MARINA BIOTECH INC.
  • MEDTRONIC INC.
  • MICROPORT SCIENTIFIC CORPORATION
  • MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL RX)
  • NOVO NORDISK
  • ORAMED PHARMACEUTICALS INC.
  • PHOSPHAGENICS LIMITED
  • SANOFI
  • SENSILE MEDICAL AG
  • THERMALIN DIABETES INC.
  • XERIS PHARMACEUTICALS
  • YPSOMED HOLDING AG

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, THROUGH 2018 ($ MILLIONS)
    • TABLE 1: DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES
    • TABLE 2: ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH RESPECT TO 2000
    • TABLE 3: HISTORY OF INSULIN ISOLATION AND DEVELOPMENT
    • TABLE 4: CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS
    • TABLE 5: ADVANTAGES AND DISADVANTAGES OF SYRINGES
    • TABLE 6: INSULIN PUMPS CURRENTLY ON THE MARKET
    • TABLE 7: COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR VARIOUS INSULIN DELIVERY SYSTEMS
    • TABLE 8: INSULIN PENS CURRENTLY ON THE MARKET
    • TABLE 9: INSULIN ADMINISTRATION ROUTES
    • TABLE 10: INSULIN DRUG APPROVALS, 2009-MARCH 2013
    • TABLE 11: PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN DEVICES, 2009--MARCH 2013
    • TABLE 12: PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN DEVICES, 2009--MARCH 2013
    • TABLE 13: SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009--APRIL 2013
    • TABLE 14: DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009--APRIL 2013
    • TABLE 15: NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
    • TABLE 16: INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND ACQUISITIONS
    • TABLE 17: LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
    • TABLE 18: INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS
    • TABLE 19: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 20: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%)
    • TABLE 21: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 22: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012 (%)
    • TABLE 23: GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 24: INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%)
    • TABLE 25: GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 26: INSULIN PEN MARKET SHARES BY REGION, 2012 (%)
    • TABLE 27: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 28: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
    • TABLE 29: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 30: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012 (%)
    • TABLE 31: GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • TABLE 32: INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%)
    • TABLE 33: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 34: GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 35: GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 36: GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 37: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
    • TABLE 38: GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • TABLE 39: INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%)
    • TABLE 40: LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS
    • TABLE 41: INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%)
    • TABLE 42: U.S. PATENTS, JANUARY 2009--MARCH 2013 (%)
    • TABLE 43: U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
    • TABLE 44: U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013
    • TABLE 45: U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
    • TABLE 46: U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, 2011-2018 ($ MILLIONS)
    • FIGURE 1: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, 2011-2018 ($ MILLIONS)
    • FIGURE 2: INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%)
    • FIGURE 3: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 4: INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%)
    • FIGURE 5: GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 6: INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%)
    • FIGURE 7: GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 8: INSULIN PEN MARKET SHARES BY REGION, 2012 (%)
    • FIGURE 9: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 10: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
    • FIGURE 11: GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, 2011-2018 ($ MILLIONS)
    • FIGURE 12: INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012 (%)
    • FIGURE 13: GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS)
    • FIGURE 14: INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%)
    • FIGURE 15: GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 16: GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 17: GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011-2018 ($ MILLIONS)
    • FIGURE 18: GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 19: INSULIN PUMP MARKET SHARES BY REGION, 2012 (%)
    • FIGURE 20: GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 21: INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%)
    • FIGURE 22: INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%)
    • FIGURE 23: U.S. PATENTS, JANUARY 2009-MARCH 2013 (%)
    • FIGURE 24: U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
    • FIGURE 25: U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
    • FIGURE 26: U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013
Back to Top